50
Participants
Start Date
December 1, 2019
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Long Term Follow-Up
"Menkes disease is a form of inherited copper deficiency associated with neurodevelopmental delays and neurological problems. Copper Histidinate is being evaluated for efficacy and safety in patients with Menkes disease. The purpose of this protocol is to collect long term follow-up data.~During the study, patients and/or parent/legal guardian will be contacted by the investigator by either telephone or an in-person visit to assess long term follow-up."
Cyprium Study Team, New York
Lead Sponsor
Cyprium Therapeutics, Inc.
INDUSTRY